Ledifos is a treatment for chronic hepatitis C, particularly genotype 1. It is a combination of two different antiviral medicines - Ledipasvir and Sofosbuvir. Ledipasvir inhibits NS5A, a phosphoprotein that helps with replication, assembly, and...
Ledifos generic harvoni recently launched in india. On october 10, 2014, the fixed-dose combination ledipasvir-sofosbuvir (harvoni) was approved by the fda for the treatment of chronic hepatitis c genotype 1 infection in adults. On november 12, 2015...